We are live on ! Find out more
CGON icon

CG Oncology
CGON

96 hedge funds and large institutions have $1.7B invested in CG Oncology in 2024 Q1 according to their latest regulatory filings, with 96 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

88.84% more ownership

Funds ownership: 0% → 88.84% (+89%)

45% less call options, than puts

Call options by funds: $48K | Put options by funds: $88K

Holders
96
Holders Change
+96
Holders Change %
–
% of All Funds
1.38%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.07%
New
96
Increased
–
Reduced
–
Closed
–
Calls
$48K
Puts
$88K
Net Calls
-$40K
Net Calls Change
-$40K

Top Buyers

Rank Fund Capital Flow
1
DC
Decheng Capital
California
+$223M
2
TCM
TCG Crossover Management
California
+$146M
3
BlackRock
BlackRock
New York
+$103M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$90.9M
5
BI
BVF Inc
California
+$77M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
51
Deerfield Management
New York
$2.09M +$1.94M +47,540 New
SC
52
Stempoint Capital
New York
$1.79M +$1.66M +40,723 New
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$1.33M +$1.24M +30,289 New
CSS
54
Cubist Systematic Strategies
Connecticut
$1.26M +$1.17M +28,672 New
Blackstone Inc
55
Blackstone Inc
New York
$1.1M +$1.02M +25,000 New
GCM
56
Ghisallo Capital Management
Massachusetts
$1.1M +$1.02M +25,000 New
SA
57
Sicart Associates
New York
$1.1M +$1.02M +25,000 New
PD
58
Point72 (DIFC)
United Arab Emirates
$1.09M +$1.01M +24,807 New
UBS Group
59
UBS Group
Switzerland
$1.02M +$953K +23,323 New
GGHC
60
Gilder Gagnon Howe & Co
New York
$813K +$756K +18,523 New
Capstone Investment Advisors
61
Capstone Investment Advisors
New York
$806K +$750K +18,354 New
Barclays
62
Barclays
United Kingdom
$718K +$668K +16,353 New
Renaissance Technologies
63
Renaissance Technologies
New York
$623K +$580K +14,200 New
Bank of America
64
Bank of America
North Carolina
$621K +$578K +14,147 New
LP
65
LMR Partners
United Kingdom
$598K +$556K +13,616 New
SRL
66
Scientech Research LLC
New Jersey
$535K +$498K +12,194 New
Invesco
67
Invesco
Georgia
$535K +$498K +12,183 New
MIM
68
MetLife Investment Management
New Jersey
$531K +$494K +12,106 New
CP
69
CenterBook Partners
Connecticut
$520K +$483K +11,836 New
BNP Paribas Financial Markets
70
BNP Paribas Financial Markets
France
$492K +$457K +11,198 New
Susquehanna International Group
71
Susquehanna International Group
Pennsylvania
$489K +$455K +11,149 New
Deutsche Bank
72
Deutsche Bank
Germany
$469K +$437K +10,693 New
Wells Fargo
73
Wells Fargo
California
$422K +$393K +9,623 New
M&T Bank
74
M&T Bank
New York
$420K +$391K +9,580 New
JP Morgan Chase
75
JP Morgan Chase
New York
$419K +$390K +9,538 New
1 2
3
4

CGON Hedge Fund Activity: Q1 2024 in Review

96 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in CG Oncology (CGON) for Q1 2024, worth a combined $1.7B.

Buyers outnumbered sellers: 96 funds opened new CGON positions and 0 closed out — a net gain of 96 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Decheng Capital, opening a new position worth an estimated $223M.

  • 96 institutional investors held CG Oncology (CGON) as of Q1 2024, up from 0 in Q4 2023.
  • Funds reported $1.7B of CG Oncology stock for Q1 2024.
  • 96 funds opened new CG Oncology positions in Q1 2024 and 0 closed out, a net change of +96 holders.
  • The largest CG Oncology buyer in Q1 2024 was Decheng Capital, an estimated $223M added.

Based on aggregated 13F filings for Q1 2024.